Related Experiment Video
Updated: Sep 2, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Risk factors for severe COVID-19 in hospitalized children in Canada: A national prospective study from March 2020-May
Daniel S Farrar1, Olivier Drouin2,3, Charlotte Moore Hepburn4,5
1Centre for Global Child Health, The Hospital for Sick Children, Toronto, Canada.
Insights
Children with technology dependence, obesity, neurologic, or pulmonary conditions face higher risks for severe COVID-19. These findings aid in prioritizing targeted therapies and vaccination strategies for pediatric populations.
Area of Science:
- Pediatric Infectious Diseases
- Epidemiology
- Public Health
Background:
- Children with chronic conditions are vulnerable to severe COVID-19.
- Limited data exists on specific risk factors and targeted therapies for pediatric COVID-19.
- This study aimed to identify severe disease predictors in hospitalized Canadian children with COVID-19.
Purpose of the Study:
- To identify factors associated with severe COVID-19 disease in hospitalized children in Canada.
- To inform targeted therapeutic interventions and vaccination strategies for at-risk pediatric populations.
Main Methods:
- A national prospective study of hospitalized children with SARS-CoV-2 infection was conducted.
- Data was collected via the Canadian Paediatric Surveillance Program (CPSP) from April 2020 to May 2021.
- Severe disease was defined for COVID-19-related hospitalizations, and risk factors were analyzed using multivariable Poisson regression.
Main Results:
- Of 330 COVID-19-related hospitalizations, 29.7% experienced severe disease.
- Children aged 2-4 and 12-17 years had higher severe disease rates.
- Comorbidities linked to severe COVID-19 included technology dependence (aRR 2.01), obesity (aRR 1.90), neurologic conditions (aRR 1.84), and pulmonary conditions (aRR 1.63).
Conclusions:
- Neurologic and pulmonary conditions, technology dependence, and obesity are significant risk factors for severe COVID-19 in children.
- Findings support the need for targeted COVID-19 therapies and vaccination prioritization for these high-risk pediatric groups.
- Continued surveillance and research are crucial for managing COVID-19 in children with comorbidities.
Background:
Children living with chronic comorbid conditions are at increased risk for severe COVID-19, though there is limited evidence regarding the risks associated with specific conditions and which children may benefit from targeted COVID-19 therapies. The objective of this study was to identify factors associated with severe disease among hospitalized children with COVID-19 in Canada.
Methods:
We conducted a national prospective study on hospitalized children with microbiologically confirmed SARS-CoV-2 infection via the Canadian Paediatric Surveillance Program (CPSP) from April 2020-May 2021. Cases were reported voluntarily by a network of >2800 paediatricians. Hospitalizations were classified as COVID-19-related, incidental infection, or infection control/social admissions. Severe disease (among COVID-19-related hospitalizations only) was defined as disease requiring intensive care, ventilatory or hemodynamic support, select organ system complications, or death. Risk factors for severe disease were identified using multivariable Poisson regression, adjusting for age, sex, concomitant infections, and timing of hospitalization.
Findings:
We identified 544 children hospitalized with SARS-CoV-2 infection, including 60·7% with COVID-19-related disease and 39·3% with incidental infection or infection control/social admissions. Among COVID-19-related hospitalizations (n=330), the median age was 1·9 years (IQR 0·1-13·3) and 43·0% had chronic comorbid conditions. Severe disease occurred in 29·7% of COVID-19-related hospitalizations (n=98/330 including 60 admitted to intensive care), most frequently among children aged 2-4 years (48·7%) and 12-17 years (41·3%). Comorbid conditions associated with severe disease included pre-existing technology dependence requirements (adjusted risk ratio [aRR] 2·01, 95% confidence interval [CI] 1·37-2·95), body mass index Z-scores ≥3 (aRR 1·90, 95% CI 1·10-3·28), neurologic conditions (e.g. epilepsy and select chromosomal/genetic conditions) (aRR 1·84, 95% CI 1·32-2·57), and pulmonary conditions (e.g. bronchopulmonary dysplasia and uncontrolled asthma) (aRR 1·63, 95% CI 1·12-2·39).
Interpretation:
While severe outcomes were detected at all ages and among patients with and without comorbidities, neurologic and pulmonary conditions as well as technology dependence were associated with increased risk of severe COVID-19. These findings may help guide vaccination programs and prioritize targeted COVID-19 therapies for children.
Funding:
Financial support for the CPSP was received from the Public Health Agency of Canada.
More Related Videos
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
09:03Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Factors Affecting Illness
For instance, risk factors are connected to illness,...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Bullying
Factors Affecting Pulmonary Ventilation
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...